Further, ICAD is not entirely explained by traditional risks like hypertension, diabetes, and dyslipidemia, and emerging factors like plasma homocysteine, angiotensin-converting enzyme polymorphism, and inflammatory cytokines may affect its development. This evidence concerns the gene ACE and metabolic syndrome.